<table>
<tbody>
<tr>
<td><p><strong>Characteristic</strong></p></td>
<td><p><strong>Placebo</strong><br />
N = 86</p></td>
<td><p><strong>Xanomeline Low Dose</strong><br />
N = 84</p></td>
<td><p><strong>Xanomeline High Dose</strong><br />
N = 84</p></td>
</tr>
<tr>
<td><p>Age</p></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td><p>    Median (Q1, Q3)</p></td>
<td><p>76 (69, 82)</p></td>
<td><p>78 (71, 82)</p></td>
<td><p>76 (71, 80)</p></td>
</tr>
<tr>
<td><p>    Mean (SD)</p></td>
<td><p>75 (9)</p></td>
<td><p>76 (8)</p></td>
<td><p>74 (8)</p></td>
</tr>
<tr>
<td><p>    Min - Max</p></td>
<td><p>52 - 89</p></td>
<td><p>51 - 88</p></td>
<td><p>56 - 88</p></td>
</tr>
<tr>
<td><p>Age Group, n (%)</p></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td><p>    &lt;65</p></td>
<td><p>14 (16.3%)</p></td>
<td><p>8 ( 9.5%)</p></td>
<td><p>11 (13.1%)</p></td>
</tr>
<tr>
<td><p>    65-80</p></td>
<td><p>42 (48.8%)</p></td>
<td><p>47 (56.0%)</p></td>
<td><p>55 (65.5%)</p></td>
</tr>
<tr>
<td><p>    &gt;80</p></td>
<td><p>30 (34.9%)</p></td>
<td><p>29 (34.5%)</p></td>
<td><p>18 (21.4%)</p></td>
</tr>
<tr>
<td><p>Female, n (%)</p></td>
<td><p>53 (61.6%)</p></td>
<td><p>50 (59.5%)</p></td>
<td><p>40 (47.6%)</p></td>
</tr>
</tbody>
</table>

